Fineline Cube

Follow:
14433 Articles
Shanghai Bao Pharmaceuticals Launches IPO to Advance Biopharmaceutical Pipeline
CompanyDeals

Shanghai Bao Pharmaceuticals Launches IPO to Advance Biopharmaceutical Pipeline

Degron Therapeutics Secures $20M Series A+ for Molecular Glue Drug Development
CompanyDeals

Degron Therapeutics Secures $20M Series A+ for Molecular Glue Drug Development

FDA Lifts Clinical Hold on Sanofi's Cialis Over-the-Counter Trial
CompanyDrug

FDA Lifts Clinical Hold on Sanofi’s Cialis Over-the-Counter Trial

Johnson & Johnson's Spravato Approved as Monotherapy for Major Depressive Disorder
CompanyDrug

Johnson & Johnson’s Spravato Approved as Monotherapy for Major Depressive Disorder

CD Biopharma Initiates Phase I Trial for CD-001 in Advanced Solid Tumors
CompanyDrug

CD Biopharma Initiates Phase I Trial for CD-001 in Advanced Solid Tumors

Kehua Bioengineering Gains NMPA Approval for Gene Polymorphism Detection Kits
CompanyMedical Device

Kehua Bioengineering Gains NMPA Approval for Gene Polymorphism Detection Kits

Humanwell's HWH340 Receives Clinical Approval for Prostate Cancer Treatment
CompanyDrug

Humanwell’s HWH340 Receives Clinical Approval for Prostate Cancer Treatment

Sichuan Biokin Re-submits IPO Application to Hong Kong Stock Exchange
CompanyDeals

Sichuan Biokin Re-submits IPO Application to Hong Kong Stock Exchange

Acotec's Vericor-S2 Coronary Microcatheter Approved by NMPA
CompanyMedical Device

Acotec’s Vericor-S2 Coronary Microcatheter Approved by NMPA

Lepu Biopharma Licenses Potential Best-in-Class ADC MRG007 to ArriVent
CompanyDeals

Lepu Biopharma Licenses Potential Best-in-Class ADC MRG007 to ArriVent

Trump Signs Executive Order to Withdraw from WHO, Drawing Criticism
Policy / Regulatory

Trump Signs Executive Order to Withdraw from WHO, Drawing Criticism

Douyin Gains Approval to Establish Hospital in Beijing's Zhongguancun
Hospital

Douyin Gains Approval to Establish Hospital in Beijing’s Zhongguancun